Cargando…
Developing Angelman syndrome-specific clinician-reported and caregiver-reported measures to support holistic, patient-centered drug development
BACKGROUND: Angelman syndrome (AS) is a rare, heterogenous neurogenetic condition, which significantly impacts the lives of people with AS and their families. Valid and reliable measures reporting key symptoms and functional impairments of AS are required to support development of patient-centered t...
Autores principales: | Connor-Ahmad, Siobhan, Tjeertes, Jorrit, Chladek, Michael, Newton, Louise, Symonds, Tara, Clinch, Susanne, Vincenzi, Brenda, McDougall, Fiona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288761/ https://www.ncbi.nlm.nih.gov/pubmed/37349793 http://dx.doi.org/10.1186/s13023-023-02729-y |
Ejemplares similares
-
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)
por: Tjeertes, Jorrit, et al.
Publicado: (2023) -
Angelman Syndrome: A Case Report
por: Ashrafzadeh, Farah, et al.
Publicado: (2016) -
Development of a clinician guide for electronic medication adherence products in older adults
por: Patel, Tejal, et al.
Publicado: (2022) -
Measuring What Matters to Individuals with Angelman Syndrome and Their Families: Development of a Patient-Centered Disease Concept Model
por: Willgoss, Tom, et al.
Publicado: (2020) -
From first report to clinical trials: a bibliometric overview and visualization of the development of Angelman syndrome research
por: Zampeta, F. Isabella, et al.
Publicado: (2022)